| Bioactivity | DGKα-IN-6 is a DGKα inhibitor with the IC50 of 1.377 nM, extracted from patent WO2022271650 (compound 143). DGKα-IN-6 has the potential for cancer study. |
| Target | 1.377 nM (DGKα) |
| Name | DGKα-IN-6 |
| CAS | 2886734-91-2 |
| Formula | C25H21F3N6 |
| Molar Mass | 462.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Codelli, Julian A., Preparation of substituted imidazoquinazolines and pyridotriazolopyrimidines as diacylglycerol kinase modulators. WO2022271650 |